ImmuPharma (GB:IMM) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
ImmuPharma PLC has announced a significant change in share ownership, with Lanstead Capital Investors LP’s voting rights crossing a threshold on August 2, 2024, resulting in their total voting rights in the company dropping from 12.99% to 9.99%. This financial movement was formally notified to the company and the relevant authorities on August 6, 2024.
For further insights into GB:IMM stock, check out TipRanks’ Stock Analysis page.
